Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Clinical trial NCT01108055 · COMPLETED

Trial details

NCT number: NCT01108055
Sponsor: Sandy Srinivas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Bladder (Urothelial, Transitional Cell) Cancer Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable

Start date: 2010-04-01
Primary completion: 2015-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.